Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942246648> ?p ?o ?g. }
- W2942246648 endingPage "562" @default.
- W2942246648 startingPage "555" @default.
- W2942246648 abstract "The study was to investigate circulating zinc-α2-glycoprotein (ZAG) concentrations in women with PCOS, and changes in ZAG levels after exenatide or metformin treatment. One hundred eighty-two women with polycystic ovary syndrome (PCOS) who met the 2003 Rotterdam diagnostic criteria and 150 controls without PCOS were recruited. We partitioned women with PCOS into groups according to body mass index or blood glucose concentrations, determined serum ZAG, anthropometric parameters, metabolic and endocrine indicators, and inflammatory markers, and statistically analyzed the results. Eighty-two overweight/obese subjects of the recruited women with PCOS were then randomly assigned to groups administered either 12 weeks of exenatide injection (10 μg b.i.d.) or oral metformin (1,000 mg b.i.d.). Circulating ZAG levels were determined after 12 weeks of treatment. The results showed that circulating ZAG was significantly lower in PCOS women than in healthy women (p < 0.01). Overweight/obese women and those with higher blood glucose levels had lower circulating ZAG. After 12 weeks of exenatide or metformin treatment, there were significant increases (p < 0.01) in circulating ZAG in both treatment groups (the exenatide baseline level was 46.54 ± 2.38 ng/mL vs. 56.41 ± 2.02 ng/mL after treatment, p < 0.01; metformin baseline was 47.81 ± 2.14 ng/mL vs. 55.67 ± 2.01 ng/mL after treatment, p < 0.01), however there was no statistical difference between the 2 treatments (p > 0.05). Circulating ZAG is closely related to PCOS and could be an important adipokine involved in the occurrence and development of PCOS. ZAG might possibly be applicable as a new observational indicator in the treatment of PCOS." @default.
- W2942246648 created "2019-05-03" @default.
- W2942246648 creator A5002661071 @default.
- W2942246648 creator A5005930092 @default.
- W2942246648 creator A5006399637 @default.
- W2942246648 creator A5011090841 @default.
- W2942246648 creator A5014969644 @default.
- W2942246648 creator A5021687717 @default.
- W2942246648 creator A5033247970 @default.
- W2942246648 creator A5038964912 @default.
- W2942246648 creator A5051180946 @default.
- W2942246648 creator A5060180233 @default.
- W2942246648 creator A5071579369 @default.
- W2942246648 creator A5083887028 @default.
- W2942246648 creator A5085273906 @default.
- W2942246648 date "2019-01-01" @default.
- W2942246648 modified "2023-09-26" @default.
- W2942246648 title "Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment" @default.
- W2942246648 cites W1975578943 @default.
- W2942246648 cites W1979355058 @default.
- W2942246648 cites W1994596431 @default.
- W2942246648 cites W2001510017 @default.
- W2942246648 cites W2002840283 @default.
- W2942246648 cites W2009155872 @default.
- W2942246648 cites W2014804054 @default.
- W2942246648 cites W2019642669 @default.
- W2942246648 cites W2044047399 @default.
- W2942246648 cites W2049962336 @default.
- W2942246648 cites W2092373761 @default.
- W2942246648 cites W2107080737 @default.
- W2942246648 cites W2109300793 @default.
- W2942246648 cites W2125769727 @default.
- W2942246648 cites W2148327577 @default.
- W2942246648 cites W2169096356 @default.
- W2942246648 cites W2173696267 @default.
- W2942246648 cites W2186218348 @default.
- W2942246648 cites W2238389938 @default.
- W2942246648 cites W2324024668 @default.
- W2942246648 cites W2330618995 @default.
- W2942246648 cites W2398771741 @default.
- W2942246648 cites W2667417500 @default.
- W2942246648 cites W2747812115 @default.
- W2942246648 doi "https://doi.org/10.1507/endocrj.ej18-0153" @default.
- W2942246648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30918134" @default.
- W2942246648 hasPublicationYear "2019" @default.
- W2942246648 type Work @default.
- W2942246648 sameAs 2942246648 @default.
- W2942246648 citedByCount "16" @default.
- W2942246648 countsByYear W29422466482019 @default.
- W2942246648 countsByYear W29422466482020 @default.
- W2942246648 countsByYear W29422466482021 @default.
- W2942246648 countsByYear W29422466482022 @default.
- W2942246648 countsByYear W29422466482023 @default.
- W2942246648 crossrefType "journal-article" @default.
- W2942246648 hasAuthorship W2942246648A5002661071 @default.
- W2942246648 hasAuthorship W2942246648A5005930092 @default.
- W2942246648 hasAuthorship W2942246648A5006399637 @default.
- W2942246648 hasAuthorship W2942246648A5011090841 @default.
- W2942246648 hasAuthorship W2942246648A5014969644 @default.
- W2942246648 hasAuthorship W2942246648A5021687717 @default.
- W2942246648 hasAuthorship W2942246648A5033247970 @default.
- W2942246648 hasAuthorship W2942246648A5038964912 @default.
- W2942246648 hasAuthorship W2942246648A5051180946 @default.
- W2942246648 hasAuthorship W2942246648A5060180233 @default.
- W2942246648 hasAuthorship W2942246648A5071579369 @default.
- W2942246648 hasAuthorship W2942246648A5083887028 @default.
- W2942246648 hasAuthorship W2942246648A5085273906 @default.
- W2942246648 hasBestOaLocation W29422466481 @default.
- W2942246648 hasConcept C126322002 @default.
- W2942246648 hasConcept C134018914 @default.
- W2942246648 hasConcept C194832188 @default.
- W2942246648 hasConcept C2777180221 @default.
- W2942246648 hasConcept C2777391703 @default.
- W2942246648 hasConcept C2779306644 @default.
- W2942246648 hasConcept C2780221984 @default.
- W2942246648 hasConcept C2780323712 @default.
- W2942246648 hasConcept C2780533449 @default.
- W2942246648 hasConcept C2780586474 @default.
- W2942246648 hasConcept C3018442814 @default.
- W2942246648 hasConcept C555293320 @default.
- W2942246648 hasConcept C71924100 @default.
- W2942246648 hasConceptScore W2942246648C126322002 @default.
- W2942246648 hasConceptScore W2942246648C134018914 @default.
- W2942246648 hasConceptScore W2942246648C194832188 @default.
- W2942246648 hasConceptScore W2942246648C2777180221 @default.
- W2942246648 hasConceptScore W2942246648C2777391703 @default.
- W2942246648 hasConceptScore W2942246648C2779306644 @default.
- W2942246648 hasConceptScore W2942246648C2780221984 @default.
- W2942246648 hasConceptScore W2942246648C2780323712 @default.
- W2942246648 hasConceptScore W2942246648C2780533449 @default.
- W2942246648 hasConceptScore W2942246648C2780586474 @default.
- W2942246648 hasConceptScore W2942246648C3018442814 @default.
- W2942246648 hasConceptScore W2942246648C555293320 @default.
- W2942246648 hasConceptScore W2942246648C71924100 @default.
- W2942246648 hasIssue "6" @default.
- W2942246648 hasLocation W29422466481 @default.
- W2942246648 hasLocation W29422466482 @default.
- W2942246648 hasOpenAccess W2942246648 @default.